Middle East respiratory syndrome is clinically different than severe acute respiratory syndrome and can lead to significant mortality rates in hospital patients who have comorbidities, according to a study in the Lancet Infectious Diseases. Researchers from Saudi Arabia said MERS can progress to respiratory failure five days earlier than SARS, although SARS appears to be more infectious in health care settings.
Researchers: Comorbidities raise MERS mortality risks
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|